During our ongoing research period, the Nobel Prize winner Bruce Beutler et al. developed an interesting specific TLR1/2 small molecule agonist Diprovocim, which has synergy with PD‐L1 antibody to eliminate melanoma in a mouse model.22 The gene discussed is TLR1; the disease is melanoma.